Genetic Variants On Chr2 And Chr16 As Markers For Use In Breast Cancer Risk Assessment, Diagnosis, Prognosis And Treatment

Abstract

The invention pertains to certain genetic variants on Chr2q14, Chr2q35 and Chr16q12 as susceptibility variants of breast cancer. Methods of risk assessment and diagnosis of increased and/or decreased susceptibility to breast cancer, using such variants are described. The invention further relates to kits for diagnosing a susceptibility to breast cancer.


Claims

Download Citation


Sign in to the Lens

Feedback